RARE
Ultragenyx Pharmaceutical Inc (RARE) Investor Questions
Review Ultragenyx Pharmaceutical Inc (RARE) faq with company data, supporting context and links to related investor research.
Research record updated: . Individual measures may refer to different reporting periods.
- Company
- Ultragenyx Pharmaceutical Inc
- Sector
- Healthcare
- Industry
- Biotechnology
- Overall BTI score
- 38
- Annual revenue
- $673.00M
- Annual net income
- $-575.00M
- Annual free cash flow
- $-472.00M
Ultragenyx Pharmaceutical Inc (RARE) Investor Questions research
Ultragenyx Pharmaceutical Inc trades under the ticker RARE. The company is classified in the Healthcare sector and the Biotechnology industry.
Investors commonly review RARE through its earnings trend, revenue, free cash flow, balance sheet, valuation and historical risk. Use the financial statements to check whether reported profit is supported by cash generation.